Literature DB >> 27052234

[Treatment of hyperglycemia in adult, critically ill patients].

Martin Clodi1,2, Michael Resl3,4, Heidemarie Abrahamian5, Bernhard Föger6, Raimund Weitgasser7,8.   

Abstract

In critical illness hyperglycemia is associated with increased mortality. Based on the currently available evidence, an intravenous insulin therapy should be initiated when blood glucose is above 180 mg/dl. After initiation of insulin therapy blood glucose should be maintained between 140 and 180 mg/dl.

Entities:  

Keywords:  Critically ill; Diabetes mellitus; Glucose lowering

Mesh：

Substances：

Year:  2016        PMID： 27052234     DOI： 10.1007/s00508-016-0987-8

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


  7 in total

1.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

2.  Intensive versus conventional glucose control in critically ill patients.

Authors:  Simon Finfer; Dean R Chittock; Steve Yu-Shuo Su; Deborah Blair; Denise Foster; Vinay Dhingra; Rinaldo Bellomo; Deborah Cook; Peter Dodek; William R Henderson; Paul C Hébert; Stephane Heritier; Daren K Heyland; Colin McArthur; Ellen McDonald; Imogen Mitchell; John A Myburgh; Robyn Norton; Julie Potter; Bruce G Robinson; Juan J Ronco
Journal:  N Engl J Med       Date:  2009-03-24       Impact factor: 91.245

3.  Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Linda L Humphrey; Roger Chou; Vincenza Snow; Paul Shekelle
Journal:  Ann Intern Med       Date:  2011-02-15       Impact factor: 25.391

Review 4.  Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data.

Authors:  Donald E G Griesdale; Russell J de Souza; Rob M van Dam; Daren K Heyland; Deborah J Cook; Atul Malhotra; Rupinder Dhaliwal; William R Henderson; Dean R Chittock; Simon Finfer; Daniel Talmor
Journal:  CMAJ       Date:  2009-03-24       Impact factor: 8.262

5.  Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.

Authors:  Renda Soylemez Wiener; Daniel C Wiener; Robin J Larson
Journal:  JAMA       Date:  2008-08-27       Impact factor: 56.272

Review 6.  Insulin therapy for the critically ill patient.

Authors:  Greet Van den Berghe
Journal:  Clin Cornerstone       Date:  2003

Review 7.  Insulin therapy in critically ill patients.

Authors:  Samer Ellahham
Journal:  Vasc Health Risk Manag       Date:  2010-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.